Skip to main content
. 2015 Feb 1;8(2):2090–2102.

Table 3.

Summary of 23 reported cases of EB virus-positive plasma cell tumors

Patients n = 22
Age (y)/gender n = 17
1.2-78 (46)
Unknown: 5
n = 16
M:F = 13:3
Unknown: 6
Underlying disease n = 11
None: 4
Chronic renal failure: 2
Hepatic failure: 1
HIV: 3
Hodgkin’s lymphoma: 1
RA: 1
Unknown: 11
Treatment n = 12
None: 6
Organ transplantation: 4
CsA: 4
AZA: 3
PSL: 5
ALG: 1
SASP: 1
MTX: 1
TAC: 1
Unknown: 10
Clinical findings n = 20
Extramedullary mass: 12
Bone lesion: 5
Ileum ulcer: 1
Shortness of breath: 1
Abdominal pain: 1
Ascites: 1
Dementia: 1
Fever: 1
Clouding of consciousness: 1
Lethargy: 1
Polyuria: 1
Polydysplasia: 1
Slurred speech: 1
Purulent rhinorrhea: 1
Dyspnea: 1
Otitis media: 1
None: 1
Unknown: 2
Type of myeloma n = 17
IgA: 1
IgG: 7
IgM: 1
κ: 9
λ: 3
Plasmacytoma: 11
Plasmablastic: 4
Non-plasmablastic: 1
Time from onset of underlying disease to that of myeloma (yr) n = 7
0.9-12 (median: 4)
No underlying disease: 4
Unknown: 11
Treatment of myeloma n = 12
Corticosteroids (incl. PSL): 2
DEXA: 2
RT: 7
Ex: 3
CT: 4
Thal: 1
BD: 1
Auto-PBSCT: 1
Immunosuppressants discont’d or dose reduced: 4
Unknown: 10
Therapeutic response n = 11
Remission (improved): 10
Not improved: 1
Unknown: 11
Outcome n = 11
Surviving: 4
DOMM: 3
Died of infection: 2
Died, cause unknown: 2
Unknown: 11